166 related articles for article (PubMed ID: 16281584)
1. [Imiquimod--a substance with a broad working spectrum].
Oster-Schmidt C
J Dtsch Dermatol Ges; 2004 Oct; 2(10):821-2. PubMed ID: 16281584
[No Abstract] [Full Text] [Related]
2. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod: a potential role in dermatology?
Eedy DJ
Br J Dermatol; 2002 Jul; 147(1):1-6. PubMed ID: 12100177
[No Abstract] [Full Text] [Related]
4. Imiquimod: a cytokine inducer.
Dahl MV
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
[No Abstract] [Full Text] [Related]
5. [Application of imiquimod and resiquimod in dermatology].
Xu KJ; Liu YH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):445-7. PubMed ID: 16900654
[TBL] [Abstract][Full Text] [Related]
6. [Imiquimod and immune response modifiers in gynaecology].
Baulon E; Vautravers A; Rodriguez B; Nisand I; Baldauf JJ
Gynecol Obstet Fertil; 2007 Feb; 35(2):149-57. PubMed ID: 17300975
[TBL] [Abstract][Full Text] [Related]
7. Focal epithelial hyperplasia (Heck's Disease) in two siblings: response to treatment with imiquimod 5% cream.
Ponte P; SerrĂ£o V; Fiadeiro T
Eur J Dermatol; 2010; 20(2):248-9. PubMed ID: 20172842
[No Abstract] [Full Text] [Related]
8. Imiquimod (Aldara cream).
Buck HW
Infect Dis Obstet Gynecol; 1998; 6(2):49-51. PubMed ID: 9702584
[No Abstract] [Full Text] [Related]
9. Imiquimod (Aldara): modifying the immune response.
Rudy SJ
Dermatol Nurs; 2002 Aug; 14(4):268-70. PubMed ID: 12240505
[TBL] [Abstract][Full Text] [Related]
10. Treatment of multifocal epithelial hyperplasia with imiquimod.
Barikbin B; Tehranchinia Z; Mozafari N
Indian J Dermatol Venereol Leprol; 2014; 80(2):175-7. PubMed ID: 24685868
[No Abstract] [Full Text] [Related]
11. Genital warts reduced with imiquimod.
AIDS Patient Care STDS; 1998 May; 12(5):409. PubMed ID: 11361984
[No Abstract] [Full Text] [Related]
12. Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors.
Miller R
Int J Dermatol; 2002 May; 41 Suppl 1():3-6. PubMed ID: 12087815
[No Abstract] [Full Text] [Related]
13. Imiquimod: mode of action and therapeutic potential.
Chosidow O; Dummer R
Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):8-11. PubMed ID: 14606276
[No Abstract] [Full Text] [Related]
14. Successful treatment of anal and perianal condyloma acuminata with imiquimod.
Tawada C; Oshitani Y; Kimura M; Seishima M
Acta Derm Venereol; 2014 Jan; 94(1):118-9. PubMed ID: 23824207
[No Abstract] [Full Text] [Related]
15. Imiquimod: a review.
Gupta AK; Browne M; Bluhm R
J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
17. New treatments for genital warts less than ideal: abstract and commentary.
Fife KH
JAMA; 1998 Jun; 279(24):2003-4. PubMed ID: 9643868
[No Abstract] [Full Text] [Related]
18. Topical imiquimod.
Pearson GW; Langley RG
J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
[TBL] [Abstract][Full Text] [Related]
19. Beyond a decade of 5% imiquimod topical therapy.
A Gaspari A; Tyring SK; Rosen T
J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
[TBL] [Abstract][Full Text] [Related]
20. To cut a long story short - the use of imiquimod in resistant warts.
Murray C
Int J STD AIDS; 2002 Apr; 13(4):275-6. PubMed ID: 11886616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]